Pancreatic cancer patients may benefit from future ... "We demonstrate the need for trials to assess changes in immune infiltration over time. Collectively, our data provides a foundation for ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies. The study which is ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

Pancreatic cancer that spreads to the liver is especially difficult to treat because the liver naturally suppresses immune responses, creating an environment where cancer can evade detection and ...

The CNSI team has developed a patented technology aimed at reprogramming the liver's immune defense to attack pancreatic cancer. They created a liver-targeting nanoparticle, billionths of a meter ...

I just wanted to extend that time." The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and attack the tumor. During surgery ...

“But mRNA vaccines are one way to train [immune systems] to detect, fight and kill cancer cells.” Raufi described the vaccine as a form of personalized treatment for pancreatic cancer patients.

Washington: According to a new study, chemotherapy affects a patient's immune system's ability to target pancreatic cancers. Led by researchers at NYU Langone Health and its Perlmutter Cancer ...